학술논문
Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling
Document Type
Article
Author
Source
In Cell Reports 23 April 2024 43(4)
Subject
Language
ISSN
2211-1247